Home › Alzheimer's Disease › New York › Syracuse
Alzheimer's Disease clinical trials in Syracuse, NY
4 studies for Alzheimer's Disease are looking for participants at sites in and around Syracuse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
RecruitingPhase 3
- SUNY Upstate Medical University, Syracuse
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RecruitingPhase 2
- Research Central LLC (DBA Ichor Research), Syracuse
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- SUNY Upstate Medical University, Syracuse
[18F]PI-2620 Phase 3 Histopathological Study
RecruitingPhase 3
- Ichor Research, Syracuse
- Velocity Clinical Research, East Syracuse · 4 mi away
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- Philadelphia, PA15 studies
- The Villages, FL15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
Other studies in Syracuse
- Non-Small Cell Lung Cancer15 studies
- Cancer (all types)9 studies
- Prostate Cancer9 studies
- Non-Muscle Invasive Bladder Cancer8 studies
- Ovarian Cancer7 studies
- Endometrial Cancer7 studies
- Obesity6 studies
- Lung Cancer6 studies
- Colorectal Cancer5 studies
- Macular Degeneration5 studies
- Acute Myeloid Leukemia5 studies
- Type 2 Diabetes5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.